Onychomycosis is nail infection caused by the fungus–Trichophyton rubrum. Currently, about 2-3% of the population in the U.S. are suffering from onynchomycosis. The infection is majorly of four types which include proximal subungual onychomycosis, distal subungual onychomycosis, and white superficial onychomycosis and candida infections of nail.
Globally, improved prevalence rate of the diabetic patients and increasing geriatric population, consistent raise in prevalence of infections, rise in consciousness among common people concerning the diagnosis and treatment, and development of the novel medications are prime growth drivers of the Onychomycosis market. Additionally, emerging economies Including India, China, and others, will create opportunities for the global Onychomycosis market. On the other hand, better circulation of off label products and the negligence towards the infection especially in underdeveloped economies are key restraints for the global Onychomycosis market.
Segment Overview
Photodynamic therapy by the treatment segment is expected to grow at a highest rate. The therapy is the most progressive treatment option available for the disease treatment. Expert medical professionals are essential to avoid any risk throughout the treatment period. However, according to WHO, there will be shortage of almost 12.9 million healthcare workforces by 2035 across the world. The demand for the plastic surgeons has surged in last few decades, however, the supply of plastic surgeons has deteriorated. The demand-supply gap of the plastic surgeons necessary to perform the photodynamic therapy treatment may deter growth of the market.
Regional Overview
The U.S. onychomycosis market is estimated to grow at healthy growth rate throughout the forecast period. The U.S. onychomycosis market is maintained by numerous growth drivers, such as increasing per capita healthcare spending, growing diabetic patients, elderly population, and introduction of new drugs. However, the market faces various challenges, such as low awareness, reimbursements, side effects, and various others.
Competitor overview
There is increasing trend of partnerships being observed among leading players in the market. Companies are entering into sales and marketing agreements for their product promotion. For instance, 2014, Anacor Pharmaceuticals Inc. come in an exclusive agreement with the Novartis AG for marketing and sales of their products in U.S. market. Moreover, 2013, Moberg Pharma engaged into a distribution agreement with the Leosons International LLC for marketing of Kerasal nail product in Middle East and North Africa.
Key Players
- Valeant PharmaceuticalsInc.,
- Galderma S.A.,
- Novartis AG, Pfizer, Inc.,
- Moberg Pharma AB,
- Johnson & Johnson Services, Inc.,
- Bayer AG,
- Dr. Reddy’s Laboratories Ltd.,
- Cipla Ltd.,
- Medimetriks Pharmaceuticals, Inc.,
- Lumenis Ltd.,
- Biofrontera AG,
- Leo Pharma A/S
Market Segmentation
By Treatment
- Drugs
- Laser
- Photodynamic Therapy
- Hospitals
- Clinics
- Others
- US
1 Introduction 6
- 1.1 Onychomycosis: An Overview 6
- 1.2 Scope of Study 6
- 1.2.1 Research Objective 6
- 1.3 Market Structure 7
- 1.4 Types of Onychomycosis 7
- 1.5 Signs and Symptoms 8
- 1.5.1 Symptoms of Onychomycosis Nail Infection Based on Subtype 8
- 1.6 Cause 9
- 1.7 Treatments for Onychomycosis 10
2 Research Methodolgy 11
- 2.1 Primary Research 12
- 2.2 Secondary Research 12
3 Market Dynamics 13
- 3.1 Growth Drivers 13
- 3.1.1 Rising Per-capita Healthcare Expenditure 13
- 3.1.2 Increasing Diabetic Patients 13
- 3.1.3 Increasing Prevalence of Peripheral Artery Disease (PAD) 13
- 3.2 Challenges 14
- 3.2.1 Low awareness 14
- 3.2.2 Side effects 14
4 US Onychomycosis 15
- 4.1 US Onychomycosis Market 15
- 4.1.1 US Onychomycosis Market By Prevalence 15
- 4.1.2 US Nail Care Market 17
- 4.2 US Jublia Drug Market 17
- 4.3 US Kerydin Drug market 19
- 4.4 US Generic Drugs Market 19
5 Competitive Landscape 21
- 5.1 Market Share Analysis 21
6 Company Profile 22
- 6.1 Novartis 22
- 6.1.1 Overview 22
- 6.1.2 Product/Business Segment Overview 22
- 6.1.3 Financial Updates 23
- 6.1.4 Key Developments 23
- 6.2 Anacor Pharmaceuticals 24
- 6.2.1 Overview 24
- 6.2.2 Financial Updates 24
- 6.2.3 Key Developments 25
- 6.3 Johnson and Johnson 26
- 6.3.1 Overview 26
- 6.3.2 Product/Business Segment Overview 26
- 6.3.3 Financial Updates 26
- 6.3.4 Key Developments 27
- 6.4 Valeant Pharmaceuticals 28
- 6.4.1 Overview 28
- 6.4.2 Product/Business Segment Overview 28
- 6.4.3 Financial Updates 29
- 6.4.4 Key Developments 29
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
